Back to Results
First PageMeta Content
Organic chemistry / Gilead Sciences / Organofluorides / Adefovir / Lamivudine / Hepatitis B / Hepatocellular carcinoma / Virus / Hepatitis B in China / Purines / Medicine / Chemistry


B.C. Ministry of Health Services Drug Coverage Decisions About PharmaCare PharmaCare Coverage Inside
Add to Reading List

Document Date: 2014-03-05 12:02:55


Open Document

File Size: 189,85 KB

Share Result on Facebook

Currency

USD / /

MedicalCondition

disease / HBV / hepatocellular carcinoma / histological active disease / cirrhosis / Hepatitis B / Chronic infections / lamivudine‐resistant HBeAg‐negative chronic hepatitis B. Hepatology / liver cancer / infection / renal dysfunction / infections / infectious disease / chronic hepatitis B. The goal / chronic hepatitis B / /

Organization

Ministry of Health Services / Canadian Expert Drug Advisory Committee / Drug Benefit Council / Pharmaceutical Services Division / B.C. Ministry of Health Services Drug Coverage Decisions About PharmaCare PharmaCare Coverage Inside B.C. PharmaCare / B.C. Ministry of Health Services Drug Coverage Decisions Adefovir / Ministry of Health Services Decision / B.C. Ministry / PharmaCare / Special Authority / Ministry of Health / /

Position

Governor / physician / /

Product

Hepsera / lamivudine / /

ProvinceOrState

British Columbia / /

PublishedMedium

the CEDAC review / /

URL

www.health.gov.bc.ca/pharmacare / www.health.gov.bc.ca/pharmacare/formulary / /

SocialTag